METHOCARBAMOL MARKET

INTRODUCTION

Methocarbamol, sold under the brand name Robaxin among others, is a medication used for short-termmusculoskeletalpain. It may be used together with rest, physical therapy, andpain medication. It is less preferred inlow back pain. It has limited use forrheumatoid arthritisandcerebral palsy. Effects generally begin within half an hour.It is taken by mouth orinjection into a vein.

Common side effect include headaches, sleepiness, and dizziness. Serious side effects may includeanaphylaxis, liver problems, confusion, andseizures. Use is not recommended inpregnancyandbreastfeeding. Because of risk of injury, skeletal muscle relaxants should generally be avoided in geriatric patients.

Methocarbamol is a centrally actingmuscle relaxant. How it works is unclear, but it does not appear to affect muscles directly. Methocarbamol was developed in the laboratories ofA. H. Robins(later acquired byPfizer).

Studies were directed towards the development ofpropanediolderivatives which possessed muscle relaxant properties superior to those ofmorpheein, which had low potency and a short duration of action.The clinical effectiveness of methocarbamol compared to other muscle relaxants is not well-known.

One trial of methocarbamol versuscyclobenzaprine, a well-studied muscle relaxant, in those with localized muscle spasm found there was no significant differences in their effects on improved muscle spasm, limitation of motion, or limitation of daily activities.

METHOCARBAMOL MARKET SIZE AND FORECAST

The Global Methocarbamol market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

METHOCARBAMOL MARKET NEW PRODUCT LAUNCH

AURO PHARMA Methocarbamol METHOCARBAMOL belongs to the group of medicines called 'muscle relaxants'. It is mainly used to relieve pain and muscle spasms occurring due to acute musculoskeletal problems.

Muscle spasm is the painful and involuntary contraction that occurs when the nerve impulses that control the muscle movements are damaged or interrupted. Secondly, it also treats tetanus conditions (lockjaw) which are characterized by painful tightening of muscles. Tetanus is a nerve disorder leading to painful muscle contraction, mainly affecting the jaw and neck muscles. 

METHOCARBAMOL consists of methocarbamol. It works by blocking pain impulses sent to the spinal cord and brain, thereby helps to maintain muscle strength and relieving muscle spasms or stiffness. 

METHOCARBAMOL MARKET COMPANY PROFILE

• Auro Pharma
• Pfizer
• Emcure pharma
• Granules
• Laurus labs

THIS METHOCARBAMOL MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Methocarbamol are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Methocarbamol and key vendor selection criteria
3. Where is the Methocarbamol manufactured? What is the average margin per unit?
4. Market share of Global Methocarbamol market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Methocarbamol in-house
6. key predictions for next 5 years in Global Methocarbamol market
7. Average B-2-B Methocarbamol market price in all segments
8. Latest trends in Methocarbamol market, by every market segment
9. The market size (both volume and value) of the Methocarbamol market in 2024-2030 and every year in between?
10. Production breakup of Methocarbamol market, by suppliers and their OEM relationship